Five Prime Therapeutics Inc (NASDAQ:FPRX)

Data as of Jan 28
 -0.33 / -1.21%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on discovering and developing novel protein therapeutics. It is building a pipeline of oncology and immunology drug by using its discovery platform. The company was founded in December 2001 by Lewis T. Williams and is headquartered in South San Francisco, CA.

Contact Information

Five Prime Therapeutics, Inc.
Two Corporate Drive
South San Francisco California 94080-7047
P:(415) 365-5600
Investor Relations:



Other institutional43.51%
Mutual fund holders18.50%
Individual stakeholders11.86%

Top Executives

Lewis T. WilliamsPresident, Chief Executive Officer & Director
Marc L. BelskyChief Financial Officer & Senior Vice President
William Michael KavanaughChief Scientific Officer & Senior VP-Research
Julie HambletonChief Medical Officer & Senior Vice President
Aron M. KnickerbockerDirector, Chief Business Officer & Senior VP

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.